Real world effectiveness of early ensitrelvir treatment in patients with SARS-CoV-2, a retrospective case series
Background: Ensitrelvir, a 3C-like protease inhibitor, received emergency approval in Japan in November 2022 for treating non-hospitalized patients with mild-to-moderate COVID-19. However, confirmation of its real-world clinical effectiveness is limited. Methods: This retrospective study evaluated 1...
Saved in:
| Main Authors: | Shuichi Abe, Dhammika Leshan Wannigama, Yu Suzuki, Daisuke Akaneya, Junko Igarashi, Mayu Suto, Kazunori Moriya, Daisuke Ishizawa, Yoshikazu Okuma, Parichart Hongsing, Cameron Hurst, Thammakorn Saethang, Paul G. Higgins, Stephen M. Stick, Anthony Kicic |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | New Microbes and New Infections |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2052297524003068 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identifying High-Risk Bacteria with Active Nasal Swab Surveillance in Intensive Care Units to Prevent Ventilator-Associated Pneumonia
by: Yu Kuramasu, et al.
Published: (2025-04-01) -
Antibiotic resistance genes in rural public places mirror the pattern of clinical antibiotic resistance prevalence
by: Dhammika Leshan Wannigama, et al.
Published: (2024-12-01) -
Treatment outcome of tuberculosis in a rural area of Japan
by: Ayaka Tateno, et al.
Published: (2024-12-01) -
Combination of curcumin or chitosan with photodynamic therapy as an effective alternative therapy for overcoming wound infection associated with multidrug-resistant Acinetobacter baumannii
by: Manta Yonpiam, et al.
Published: (2025-06-01) -
First human case of Eidernor doerrieniae colonization in a peritoneal dialysis catheter: A warning from silent contamination
by: Phichit Songviriyavithaya, et al.
Published: (2025-03-01)